Ti‐Chun Chan

689 total citations
43 papers, 456 citations indexed

About

Ti‐Chun Chan is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ti‐Chun Chan has authored 43 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Surgery and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ti‐Chun Chan's work include Bladder and Urothelial Cancer Treatments (18 papers), Ferroptosis and cancer prognosis (15 papers) and Epigenetics and DNA Methylation (14 papers). Ti‐Chun Chan is often cited by papers focused on Bladder and Urothelial Cancer Treatments (18 papers), Ferroptosis and cancer prognosis (15 papers) and Epigenetics and DNA Methylation (14 papers). Ti‐Chun Chan collaborates with scholars based in Taiwan and Thailand. Ti‐Chun Chan's co-authors include Chien‐Feng Li, Yow‐Ling Shiue, Wen‐Jeng Wu, Tzu‐Ju Chen, Wei‐Ming Li, Peir‐In Liang, Chung‐Hsi Hsing, Bi‐Wen Yeh, Steven K. Huang and Hong-Lin He and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Ti‐Chun Chan

42 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ti‐Chun Chan Taiwan	14	255	146	104	103	97	43	456
Juanjo Lozano Spain	3	336 1.3×	99 0.7×	233 2.2×	102 1.0×	116 1.2×	6	560
Jingping Ge China	10	368 1.4×	193 1.3×	60 0.6×	67 0.7×	102 1.1×	38	588
Roy Ehrnström Sweden	13	339 1.3×	206 1.4×	82 0.8×	183 1.8×	133 1.4×	24	615
Xiaheng Deng China	13	517 2.0×	458 3.1×	121 1.2×	52 0.5×	63 0.6×	33	682
Liqian Ma United States	10	145 0.6×	151 1.0×	156 1.5×	68 0.7×	34 0.4×	20	367
Huinan Qu China	10	228 0.9×	124 0.8×	22 0.2×	74 0.7×	75 0.8×	17	402
Kai Yan China	12	364 1.4×	186 1.3×	25 0.2×	130 1.3×	49 0.5×	14	514
Virginie Maire France	9	401 1.6×	165 1.1×	56 0.5×	247 2.4×	138 1.4×	17	697
Elena Panizza United States	11	290 1.1×	114 0.8×	37 0.4×	73 0.7×	57 0.6×	19	399

Countries citing papers authored by Ti‐Chun Chan

Since Specialization

Citations

This map shows the geographic impact of Ti‐Chun Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ti‐Chun Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ti‐Chun Chan more than expected).

Fields of papers citing papers by Ti‐Chun Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ti‐Chun Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ti‐Chun Chan. The network helps show where Ti‐Chun Chan may publish in the future.

Co-authorship network of co-authors of Ti‐Chun Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Ti‐Chun Chan. A scholar is included among the top collaborators of Ti‐Chun Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ti‐Chun Chan. Ti‐Chun Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Wei‐Ming, Ti‐Chun Chan, Yu‐Ching Wei, et al.. (2023). Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis. Frontiers in Bioscience-Landmark. 28(9). 217–217. 2 indexed citations

Chan, Ti‐Chun, Yow‐Ling Shiue, & Chien‐Feng Li. (2023). The biological impacts of CEBPD on urothelial carcinoma development and progression. Frontiers in Oncology. 13. 1123776–1123776. 5 indexed citations

Sun, Ding‐Ping, Tzu‐Ju Chen, Steven K. Huang, et al.. (2023). Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma. Scientific Reports. 13(1). 17444–17444. 2 indexed citations

He, Hong-Lin, Ti‐Chun Chan, Chung‐Hsi Hsing, et al.. (2023). Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder. World Journal of Surgical Oncology. 21(1). 62–62. 2 indexed citations

Liang, Peir‐In, Ti‐Chun Chan, Wei‐Ming Li, et al.. (2023). Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma. BMC Cancer. 23(1). 599–599. 3 indexed citations

Chan, Ti‐Chun, Yi‐Ting Chen, Kien Thiam Tan, et al.. (2021). Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis. SHILAP Revista de lepidopterología. 11(12). e674–e674. 14 indexed citations

Chen, Tzu‐Ju, Ti‐Chun Chan, Wan‐Shan Li, et al.. (2021). Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma. Genes. 12(6). 872–872. 12 indexed citations

Chen, Tzu‐Ju, Chia‐Lin Chou, Yufeng Tian, et al.. (2021). High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT. International Journal of Clinical Oncology. 26(9). 1689–1697. 9 indexed citations

Chen, Tzu‐Ju, Ti‐Chun Chan, Hong-Lin He, et al.. (2021). High G protein subunit beta 4 protein level is correlated to poor prognosis of urothelial carcinoma. Medical Molecular Morphology. 54(4). 356–367. 6 indexed citations

10.

Kuo, Yu‐Hsuan, Ti‐Chun Chan, Tzu‐Ju Chen, et al.. (2021). Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma. Frontiers in Oncology. 11. 749142–749142. 13 indexed citations

11.

Chien, Tsu‐Ming, Ti‐Chun Chan, Steven K. Huang, et al.. (2020). Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis. Cancers. 12(3). 630–630. 20 indexed citations

12.

Li, Wei‐Ming, Ti‐Chun Chan, Steven K. Huang, et al.. (2020). Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma. Frontiers in Oncology. 10. 570340–570340. 9 indexed citations

13.

Chan, Ti‐Chun, Wen‐Jeng Wu, Wei‐Ming Li, et al.. (2020). SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma. Theranostics. 10(25). 11775–11793. 22 indexed citations

14.

Pan, Cheng‐Tang, Ti‐Chun Chan, Wen‐Jeng Wu, et al.. (2019). Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma. Theranostics. 10(2). 707–724. 15 indexed citations

15.

Chan, Ti‐Chun, Yufeng Tian, Peir‐In Liang, et al.. (2019). High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder. Urologic Oncology Seminars and Original Investigations. 37(5). 299.e7–299.e18. 9 indexed citations

16.

Li, Chien‐Feng, Fu‐Min Fang, Yen‐Yang Chen, et al.. (2017). Overexpressed Fatty Acid Synthase in Gastrointestinal Stromal Tumors: Targeting a Progression-Associated Metabolic Driver Enhances the Antitumor Effect of Imatinib. Clinical Cancer Research. 23(16). 4908–4918. 33 indexed citations

17.

Li, Chien‐Feng, Ti‐Chun Chan, Yuhui Wang, et al.. (2017). Transmembrane and Coiled-Coil Domain 1 Impairs the AKT Signaling Pathway in Urinary Bladder Urothelial Carcinoma: A Characterization of a Tumor Suppressor. Clinical Cancer Research. 23(24). 7650–7663. 27 indexed citations

18.

Chang, Shih‐Lun, Ti‐Chun Chan, Tzu‐Ju Chen, et al.. (2017). HOXC6 Overexpression Is Associated With Ki-67 Expression and Poor Survival in NPC Patients. Journal of Cancer. 8(9). 1647–1654. 25 indexed citations

19.

Yen, Shao‐Lun, Chien‐Feng Li, Ti‐Chun Chan, et al.. (2016). Overexpression of Transient Receptor Protein Cation Channel Subfamily A Member 1, Confers an Independent Prognostic Indicator in Nasopharyngeal Carcinoma. Journal of Cancer. 7(10). 1181–1188. 18 indexed citations

20.

Fang, Kuan‐Min, Ti‐Chun Chan, Jun‐Jen Liu, et al.. (2013). Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions. Glia. 61(9). 1402–1417. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact